This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
BrainsWay is an innovative medical device company specializing in an FDA cleared, noninvasive treatment known as Transcranial Magnetic Stimulation, or TMS, which is used to treat psychiatric conditions. TMS uses a magnetic field to stimulate a specific target region in the brain that controls mood, using it to treat symptoms of Major Depressive Disorder (MDD), by activating the neural pathways. BrainsWay offers a unique type of TMS treatment known as Deep TMS which has proven to be more accurate and efficient in targeting the brain while maintaining safe levels of stimulation. BrainsWay’s Deep TMS is patented and FDA cleared to treat both MDD and Obsessive Compulsive Disorder (OCD), making it the only TMS solution that has been proven to treat patients suffering from OCD.
The BrainsWay device uses advanced technology and comes in the form of a helmet that is worn during treatment. Treatment for MDD occurs five times a week for four weeks, and then twice a week for an additional 12 weeks as needed for maintenance. People suffering from OCD have five treatment sessions a week for five weeks followed by four sessions in the sixth week. BrainsWay’s helmet is currently being sold and leased to TMS clinics across North America and elsewhere. BrainsWay’s extensive Research and Development team is actively working to create additional treatment applications for Opioid addiction, PTSD, smoking cessation and many more conditions.
About 40% of individuals suffering from depression are shown to be treatment-resistant, meaning antidepressants are either ineffective or carry unbearable side effects. TMS has proven successful in more than half of those with treatment-resistant depression. Many who showed successful results from the trial, achieved full remission with BrainsWay’s Deep TMS.
One third of those treated for OCD with BrainsWay’s Deep TMS also showed promising results, experiencing over 30% reduction of symptoms after failing to respond to other, more common treatments. BrainsWay’s Deep TMS not only works more effectively but at higher rates than other TMS products on the market.
BrainsWay’s Deep TMS is not only a proven method to treat MDD and OCD but also one with almost no side effects. Most people receiving treatment don’t feel anything during or after the treatment other than a tapping and knocking sensation. A small percentage of patients experience some discomfort and pain around the application area or jaw, but adjusting the helmet often resolves these sensations. Additionally, the pain and discomfort attributed to the treatment tend to improve or go away altogether during consecutive sessions. While most people who suffer from these conditions give up after medication or psychotherapy fails to produce desired results, BrainsWay’s TMS offers an alternative with a high success rate and virtually no side effects.
BrainsWay’s Deep TMS treatment costs vary based on the specific clinic performing the treatment. Most private medical insurance companies do cover TMS treatment for MDD. However, Deep TMS for OCD is not yet covered by insurers and BrainsWay is working diligently to extend the coverage.